Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

New Providence, Rhode Island Clinical Trials

A listing of New Providence, Rhode Island clinical trials actively recruiting patient volunteers.

RESULTS

Found (50) clinical trials

A Study to Evaluate the Efficacy and Safety of ANB019 in Subjects With Generalized Pustular Psoriasis

This is a Phase II single arm multiple dose study to assess the efficacy and safety, and PK of ANB019 in subjects with Generalized Pustular Psoriasis

Phase

8.2 miles

Learn More »

A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis

The primary objective is to provide dose-ranging data for 4 dose regimens of BI 655130 compared to placebo on the primary endpoint of percentage change from baseline in PPP ASI at Week 16. The target dose(s) will be estimated from the model by incorporating information on the minimum clinically relevant ...

Phase

8.2 miles

Learn More »

A Study to Compare FCD105 Foam to Minocycline 3% Foam Adapalene 0.3% Foam and Vehicle Foam.

A study comparing FCD105 to 3% minocycline foam, 0.3% adapalene foam and vehicle foam in patients 12 years old for the treatment of moderate-to-severe acne.

Phase

8.2 miles

Learn More »

Study to Assess the Efficacy and Safety of LYS006 in Patients With Moderate to Severe Inflammatory Acne

The main purpose of this study is to assess preliminary efficacy and safety of LYS006 in patients with moderate to severe inflammatory acne and to determine if LYS006 has an adequate clinical profile for further clinical development.

Phase

8.2 miles

Learn More »

A Study to Assess the Efficacy Safety and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

Participants with diseases characterized by chronic pruritus experiencing moderate to severe pruritus will be enrolled in this pilot Phase 2 study. The diseases characterized by chronic pruritus investigated in this pilot study currently include chronic idiopathic urticaria (CIU), chronic idiopathic pruritus (CIP), lichen planus (LP), lichen simplex chronicus (LSC) and ...

Phase

8.2 miles

Learn More »

Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis

A Phase 2, multicenter, randomized, placebo-controlled, double-blind, parallel-group study for subjects with moderate to severe AD whose disease cannot be adequately controlled with topical medications or for whom topical treatment is medically inadvisable.

Phase

8.2 miles

Learn More »

A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis

The reason for this study is to see if the study drug LY3375880 is safe and effective in adults with moderate-to-severe atopic dermatitis (AD).

Phase

8.2 miles

Learn More »

A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is

To assess long-term safety, tolerability, and efficacy of BI 730357 in patients with moderate to severe chronic plaque psoriasis.

Phase

8.2 miles

Learn More »

A phase 2 research study of a subcutaneous injection of investigational medication for adults ages 18 and older with moderate to severe atopic dermatitis, who have not received prior treatment with dupilumab. Note: Study participants will receive either the investigational medication or placebo. The trial comprises four periods: screening (up ...

Phase

8.2 miles

Learn More »

A Study to Evaluate the Efficacy and Safety of ANB019 in Subjects With Palmoplantar Pustulosis

This study is a Phase II, randomized, placebo-controlled, double-blind, multiple dose study to evaluate the efficacy and safety, and PK of ANB019 in subjects with Palmoplantar Pustulosis

Phase

8.2 miles

Learn More »